257 top medical experts on Neurogenic Diabetes Insipidus across 38 countries and 20 U.S. states, including 116 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Neurogenic Diabetes Insipidus: A genetic or acquired polyuric disorder caused by a deficiency of vasopressins secreted by the neurohypophysis. Clinical signs include the excretion of large volumes of dilute urine; hypernatremia; thirst; and polydipsia. Etiologies include head trauma; surgeries and diseases involving the hypothalamus and the pituitary gland. This disorder may also be caused by mutations of genes such as arvp encoding vasopressin and its corresponding neurophysin (neurophysins).
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Diabetes Insipidus (1,413).
  4. Clinical Trials ClinicalTrials.gov : at least 10 including 4 Completed, 4 Recruiting


  

        

                    


    These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

  1. Eugster, Erica A   Pediatric Endocrinology  Google Publications
    Division of Pediatric Endocrinology, Department of Pediatrics, Riley Hospital for Children at Indiana University Health, Indianapolis, IN.
    Physician 
    Disclosed payments from biomedical company (Eton Pharmaceuticals, Inc.) in 2021 for $4,500.28
    Subjects: Diabetes Insipidus, Neurogenic; Antidiuretic Agents; Deamino Arginine Vasopressin; Polydipsia; Polyuria
    Categories: Epidemiology; Administration & Dosage; Drug Therapy
    INCIDENCE OF CENTRAL DIABETES INSIPIDUS IN CHILDREN PRESENTING WITH POLYDIPSIA AND POLYURIA. (2016)
    Variability in Oral Desmopressin Dose Requirements in Children with Central Diabetes Insipidus. (2021)

  2. Miller, Karen K   Endocrinology, Diabetes & Metabolism  Google Publications
    Neuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts, USA. Top Hospital
    Physician  Case Reports 
    Disclosed payments in 2021 from 2 biomedical companies, totalling $64.54, including $64.54 from  Novo Nordisk Inc
    Subjects: Diabetes Insipidus, Neurogenic; Antineoplastic Agents, Alkylating; Bone Density; Dacarbazine; Hypopituitarism; Oxytocin
    Categories: Blood; Chemically Induced; Adverse Effects; Analogs & Derivatives; Complications; Pathology
    Central diabetes insipidus: a previously unreported side effect of temozolomide. (2013)
    Lower Oxytocin Levels Are Associated with Lower Bone Mineral Density and Less Favorable Hip Geometry in Hypopituitary Men. (2021)

  3. Christ-Crain, Mirjam   Google Publications
    Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine and Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
    Scientist  Highly Cited  Highly Published 
    Subjects: Diabetes Insipidus, Neurogenic; Glycopeptides; Diabetes Insipidus, Nephrogenic; Polydipsia; Polydipsia, Psychogenic; Polyuria
    Categories: Diagnosis; Therapy; Administration & Dosage; Blood; Drug Effects; Physiopathology
    ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of diabetes insipidus and hyponatraemia. (2020)
    Diagnostic Accuracy of Copeptin in the Differential Diagnosis of the Polyuria-polydipsia Syndrome: A Prospective Multicenter Study. (2015)

  4. Caturegli, Patrizio   Anatomic Pathology & Clinical Pathology  Google Publications
    Physician  Case Reports 
    Subjects: Diabetes Insipidus, Neurogenic; Adaptor Proteins, Signal Transducing; Autoantibodies; Autoimmune Hypophysitis; Facial Paralysis; Immunologic Factors
    Categories: Drug Therapy; Immunology; Therapeutic Use; Blood
    Rabphilin-3A as a Targeted Autoantigen in Lymphocytic Infundibulo-neurohypophysitis. (2015)
    Autoimmune lymphocytic hypophysitis in association with autoimmune eye disease and sequential treatment with infliximab and rituximab. (2015)

  5. Lussier, Yoann  Google Publications
    Department of Pharmacology and Physiology, University of Montreal, Montreal, Quebec, Canada.
    Scientist 
    Subjects: Diabetes Insipidus, Neurogenic; Endoplasmic Reticulum-Associated Degradation
    Mice deficient for ERAD machinery component Sel1L develop central diabetes insipidus. (2017)

  6. Arima, Hiroshi   Google Publications
    Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.
    Scientist  Highly Cited  Highly Published  Clinical Trial 
    Subjects: Diabetes Insipidus, Neurogenic; Neurons; Vasopressins; Arginine Vasopressin; Antidiuretic Agents; Autophagy
    Categories: Metabolism; Pathology; Administration & Dosage; Immunology; Physiology; Physiopathology
    Rabphilin-3A as a Targeted Autoantigen in Lymphocytic Infundibulo-neurohypophysitis. (2015)
    Adipsia increases risk of death in patients with central diabetes insipidus. (2014)

  7. Kim, Soo Wan   Anesthesiology  Google Publications
    Department of Internal Medicine, Chonnam National University Medical School.
    Physician  Case Reports 
    Subjects: Diabetes Insipidus, Neurogenic; Central Nervous System Cysts; Diagnostic Errors; Oligohydramnios; Ophthalmoplegia; Otitis Externa
    Categories: Diagnosis; Etiology; Complications
    Diabetes Insipidus Presenting with Oligohydramnios and Polyuria During Pregnancy. (2018)
    Central Diabetes Insipidus Associated with Orbital Apex Syndrome. (2019)

  8. Oiso, Yutaka   Google Publications
    Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.
    Scientist  Highly Cited  Highly Published  Clinical Trial 
    Subjects: Diabetes Insipidus, Neurogenic; Neurons; Antidiuretic Agents; Deamino Arginine Vasopressin; Polyuria; Vasopressins
    Categories: Administration & Dosage; Drug Therapy; Immunology; Metabolism; Pathology; Physiopathology
    Rabphilin-3A as a Targeted Autoantigen in Lymphocytic Infundibulo-neurohypophysitis. (2015)
    Clinical review: Treatment of neurohypophyseal diabetes insipidus. (2013)

  9. Di, Iorgi Natascia  Google Publications
    Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, Genova, Italy.
    Scientist  Highly Published  Case Reports 
    Subjects: Diabetes Insipidus, Neurogenic; Neurophysins; Protein Precursors; Vasopressins; Brain Injuries; Brain Neoplasms
    Categories: Genetics; Diagnosis; Diagnostic Imaging; Etiology
    Central diabetes insipidus in children and young adults: etiological diagnosis and long-term outcome of idiopathic cases. (2014)
    Management of diabetes insipidus and adipsia in the child. (2015)

  10. Maghnie, Mohamad   Google Publications
    Department of Pediatrics, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
    Scientist  Highly Cited  Highly Published  Case Reports 
    Subjects: Diabetes Insipidus, Neurogenic; Neurophysins; Protein Precursors; Vasopressins; Brain Injuries; Brain Neoplasms
    Categories: Genetics; Diagnosis; Diagnostic Imaging; Etiology; Methods; Therapy
    Central diabetes insipidus in children and young adults: etiological diagnosis and long-term outcome of idiopathic cases. (2014)
    Central diabetes insipidus in children: Diagnosis and management. (2020)

  11. Bellastella, Giuseppe    Google Publications
    Departments of Medical, Surgical, Neurological, Metabolic and Geriatric SciencesClinical and Experimental MedicineCardiothoracic and Respiratory SciencesSecond University of Naples, Piazza L. Miraglia 2, 80131 Napoli, Italy.
    Physician  Highly Published  Case Reports 
    Subjects: Autoimmune Diseases; Diabetes Insipidus, Neurogenic; Autoantibodies; Arginine Vasopressin; Hypopituitarism; Hypothalamus
    Categories: Immunology; Pathology; Etiology
    Involvement of hypothalamus autoimmunity in patients with autoimmune hypopituitarism: role of antibodies to hypothalamic cells. (2012)
    Subclinical diabetes insipidus. (2012)

  12. Roth, Christian L   Pediatric Endocrinology  Google Publications
    Physician 
    Medical school: Other (MD, 1990)
    Medicare Accepted
    Subjects: Diabetes Insipidus, Neurogenic; Nervous System Malformations; Brain
    Categories: Epidemiology; Abnormalities; Complications; Etiology
    Pediatric Central Diabetes Insipidus: Brain Malformations Are Common and Few Patients Have Idiopathic Disease. (2015)

  13. Kumar, Saumya   Endocrinology, Diabetes & Metabolism   Google Publications
    Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.
    Physician  Case Reports 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 90/100
    Disclosed payments in 2021 from 3 biomedical companies, totalling $47.98, including $30.54 from  Novo Nordisk Inc
    Subjects: Diabetes Insipidus, Neurogenic; Hypopituitarism
    Categories: Diagnosis
    Sheehan syndrome presenting as central diabetes insipidus: a rare presentation of an uncommon disorder. (2011)

  14. Thompson, Chris J   Google Publications
    Academic Department of Endocrinology, Beaumont Hospital/RCSI Medical School, Dublin, Ireland.
    Scientist  Highly Cited  Highly Published  Case Reports 
    Subjects: Diabetes Insipidus, Neurogenic; Hyponatremia; Antidiuretic Agents; Arginine Vasopressin; Autoimmune Diseases; Brain Injuries
    Categories: Therapy; Complications; Physiopathology; Administration & Dosage; Physiology; Deficiency
    ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of diabetes insipidus and hyponatraemia. (2020)
    Acute glucocorticoid deficiency and diabetes insipidus are common after acute traumatic brain injury and predict mortality. (2013)

  15. Rutishauser, Jonas   Google Publications
    University of Basel, Biozentrum, Klingelbergstrasse 50/70, CH-4056 Basel, Switzerland; Kantonsspital Baden, Clinical Trial Unit, Im Ergel 1, CH-5405 Baden, Switzerland. Electronic address: .
    Scientist  Highly Published 
    Subjects: Diabetes Insipidus, Neurogenic; Vasopressins; Neurophysins; Protein Aggregates; Amyloid; Diabetes Insipidus, Nephrogenic
    Categories: Genetics; Diagnosis; Metabolism; Physiology; Blood; Classification
    Diagnostic Accuracy of Copeptin in the Differential Diagnosis of the Polyuria-polydipsia Syndrome: A Prospective Multicenter Study. (2015)
    Role of protein aggregation and degradation in autosomal dominant neurohypophyseal diabetes insipidus. (2020)

  16. Liebman, Scott   Nephrology  Google Publications
    Physician  Case Reports 
    Medical school: State University of Ny Upstate Medical University (MD, 1997)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 85/100
    Subjects: Diabetes Insipidus, Neurogenic; Leukemia, Myeloid, Acute
    Categories: Complications; Diagnosis
    Central diabetes insipidus in the setting of acute myelogenous leukemia. (2012)

  17. Bando, Hironori  Google Publications
    Division of Diabetes and Endocrinology, Department of Internal Medicine.
    Scientist  Case Reports 
    Subjects: Diabetes Insipidus, Neurogenic; Hypopituitarism; Pituitary Diseases
    Categories: Epidemiology
    The prevalence of IgG4-related hypophysitis in 170 consecutive patients with hypopituitarism and/or central diabetes insipidus and review of the literature. (2014)

  18. Brownell, Isaac   Dermatology  Google Publications
    Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
    Physician  Case Reports 
    Subjects: Antibodies, Monoclonal; B7-H1 Antigen; Diabetes Insipidus, Neurogenic
    Categories: Drug Therapy; Immunology; Therapeutic Use
    Anti-PD-L1 Treatment Induced Central Diabetes Insipidus. (2018)

  19. Perrotta, Silverio    Google Publications
    Department of Women, Child and General and Specialized Surgery, University of Campania Luigi Vanvitelli, Naples, Italy.
    Physician  Highly Published  Case Reports 
    Subjects: Diabetes Insipidus, Neurogenic; Neurophysins; Protein Precursors; Vasopressins; Bartter Syndrome; Family
    Categories: Genetics; Complications; Diagnosis; Diagnostic Imaging; Urine
    Familial neurohypophyseal diabetes insipidus in 13 kindreds and 2 novel mutations in the vasopressin gene. (2019)
    Early-onset central diabetes insipidus is associated with de novo arginine vasopressin-neurophysin II or Wolfram syndrome 1 gene mutations. (2015)

  20. Bichet, Daniel G   Google Publications
    Professor of Medicine, Pharmacology and Physiology, University of Montreal, and Nephrology Service, Research Center, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada.
    Scientist  Highly Published  Clinical Trial 
    Subjects: Diabetes Insipidus, Neurogenic; Antidiuretic Agents; Deamino Arginine Vasopressin; Endoplasmic Reticulum-Associated Degradation
    Categories: Pharmacokinetics; Therapeutic Use; Diagnosis; Drug Therapy; Genetics; Urine
    Desmopressin duration of antidiuretic action in patients with central diabetes insipidus. (2011)
    Genetics and diagnosis of central diabetes insipidus. (2012)

Note:
  1. These experts have limited publications on this topic in our database, so expertise assessment may not be accurate.
  2. Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.
These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads or screen scraping) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

);